Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Hypertension Reports

• Publication date

  2017-02-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11906-017-0713-6PMID 28243928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension

  2016cited by this paper
• The hidden endoscopic burden of sleeve gastrectomy and its comparison with Roux-en-Y gastric bypass

  2016cited by this paper
• Relationship Between Obesity, Hypertension, and Aldosterone Production in Postmenopausal African American Women: A Pilot Study

  2016cited by this paper
• Surgical management of super–super obese patients: Roux-en-Y gastric bypass versus sleeve gastrectomy

  2016cited by this paper
• The Role of PVH Circuits in Leptin Action and Energy Balance.

  2016cited by this paper
• Clinical Factors Associated With Remission of Obesity-Related Comorbidities After Bariatric Surgery.

  2016cited by this paper
• Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome

  2016cited by this paper
• Obesity, hypertension and aldosterone: is leptin the link?

  2016cited by this paper
• Obesity, Hypoxemia, and Hypertension: Mechanistic Insights and Therapeutic Implications.

  2016cited by this paper
• Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension

  2016cited by this paper
• Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects

  2016cited by this paper
• Safety and efficacy of 1020 consecutive laparoscopic sleeve gastrectomies performed as a primary treatment modality for morbid obesity. A single-center experience from the metabolic and bariatric surgical accreditation quality and improvement program

  2016cited by this paper
• Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis

  2016cited by this paper
• Obesity and cardiovascular disease: friend or foe?

  2016cited by this paper
• Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.

  2016cited by this paper
• Obesity-Induced Hypertension: Brain Signaling Pathways

  2016cited by this paper
• Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges

  2016cited by this paper
• Roux-En-Y Gastric Bypass Vs. Sleeve Gastrectomy: Balancing the Risks of Surgery with the Benefits of Weight Loss

  2016cited by this paper
• The Obesity Epidemic--Understanding the Disease and the Treatment.

  2016cited by this paper
• Telmisartan Ameliorates Nephropathy in Metabolic Syndrome by Reducing Leptin Release From Perirenal Adipose Tissue

  2016cited by this paper
• Say NO to Obesity-Related Hypertension: Role of the L-Arginine–Nitric Oxide Pathway

  2016cited by this paper
• Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future.

  2016cited by this paper
• Cardiovascular Regulation by the Arcuate Nucleus of the Hypothalamus: Neurocircuitry and Signaling Systems

  2016cited by this paper
• Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients

  2016cited by this paper
• Strong independent association between obesity and essential hypertension

  2016cited by this paper
• Management of obesity.

  2016cited by this paper
• Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come.

  2016cited by this paper
• Treatment of Obesity: Weight Loss and Bariatric Surgery.

  2016cited by this paper
• 4A.07: PREVALENCE AND RISK FACTORS FOR REFRACTORY HYPERTENSION IN THE DENERHTN STUDY

  2015cited by this paper
• Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

  2015cited by this paper
• Baroreflex Activation Therapy Lowers Arterial Pressure Without Apparent Stimulation of the Carotid Bodies

  2015cited by this paper
• Pathophysiological role of host microbiota in the development of obesity

  2015cited by this paper
• The sympathetic nervous system alterations in human hypertension.

  2015cited by this paper
• An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.

  2015cited by this paper
• Baroreflex activation therapy in patients with end-stage renal failure: proof of concept

  2015cited by this paper
• Carotid baroreflex activation therapy for resistant hypertension

  2015cited by this paper
• Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?

  2015cited by this paper
• Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic

  2015cited by this paper
• Design of renal denervation studies not confounded by antihypertensive drugs.

  2015cited by this paper
• Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.

  2015cited by this paper
• Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery.

  2015cited by this paper
• Inflammation, immunity, and hypertensive end-organ damage.

  2015cited by this paper
• Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care

  2015cited by this paper
• Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.

  2015cited by this paper
• Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?

  2015cited by this paper
• A Retrospective Review of the Medical Management of Hypertension and Diabetes Mellitus Following Sleeve Gastrectomy

  2015cited by this paper
• Obstructive sleep apnea, hypertension and cardiovascular diseases

  2015cited by this paper
• Bariatric and metabolic surgery: a shift in eligibility and success criteria

  2015cited by this paper
• Hypothalamic Signaling Mechanisms in Hypertension

  2015cited by this paper
• The path to prevention and treatment of resistant hypertension.

  2015cited by this paper
• Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis

  2015cited by this paper
• Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patients with resistant hypertension

  2015cited by this paper
• Implications of Renal Denervation Therapy in Patients with Sleep Apnea

  2015cited by this paper
• New developments in the pathogenesis of obesity-induced hypertension.

  2015cited by this paper
• Role of the Paraventricular Nucleus of the Hypothalamus in the Sympathoexcitatory Effects of Leptin

  2015cited by this paper
• Effects of Continuous Positive Airway Pressure Treatment on Clinic and Ambulatory Blood Pressures in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Randomized Controlled Trial

  2015cited by this paper
• Device-based approaches for renal nerve ablation for hypertension and beyond

  2015cited by this paper
• Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension

  2015cited by this paper
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  2015cited by this paper
• The double challenge of resistant hypertension and chronic kidney disease.

  2015cited by this paper
• Renal denervation therapy for hypertension: pathways for moving development forward.

  2015cited by this paper
• Bilateral or Unilateral Stimulation for Baroreflex Activation Therapy

  2015cited by this paper
• Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.

  2015cited by this paper
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  2015cited by this paper
• Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic.

  2015cited by this paper
• Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension

  2015cited by this paper
• Weight Gain After Fecal Microbiota Transplantation

  2015cited by this paper
• Acute on/off effects and chronic blood pressure reduction after long-term baroreflex activation therapy in resistant hypertension

  2015cited by this paper
• Long-Term Effects of Bariatric Surgery on Type II Diabetes, Hypertension and Hyperlipidemia: A Meta-Analysis and Meta-Regression Study with 5-Year Follow-Up

  2015cited by this paper
• Renal denervation for treatment of drug-resistant hypertension.

  2015cited by this paper
• Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure?

  2015cited by this paper
• Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients

  2014cited by this paper
• Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery

  2014cited by this paper
• The Autonomic Nervous System and Hypertension

  2014cited by this paper
• Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

  2014cited by this paper
• Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.

  2014cited by this paper
• Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias

  2014cited by this paper
• Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity.

  2014cited by this paper
• Refractory hypertension: an important clinical phenotype.

  2014cited by this paper
• Obesity-related hypertension: possible pathophysiological mechanisms.

  2014cited by this paper
• Outcome of sleeve gastrectomy as a primary bariatric procedure

  2014cited by this paper
• Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss.

  2014cited by this paper
• Mineralocorticoid receptor, the main player in aldosterone-induced large artery stiffness.

  2014cited by this paper
• Microbiota, antibiotics, and obesity.

  2014cited by this paper
• Surgery for weight loss in adults.

  2014cited by this paper
• Chemoreflexes, Sleep Apnea, and Sympathetic Dysregulation

  2014cited by this paper
• Erratum to: Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity and Related Comorbidities: A Meta-Analysis of 21 Studies

  2014cited by this paper
• Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.

  2014cited by this paper
• The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.

  2014cited by this paper
• Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

  2014cited by this paper
• Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity and Related Comorbidities: A Meta-Analysis of 21 Studies

  2014cited by this paper
• Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Diabetes Mellitus, Hypertension and Dyslipidaemia in Morbidly Obese Patients

  2014cited by this paper
• Should Patients with Obesity and Hypertension be Treated Differently from Those Who Are Not Obese?

  2014cited by this paper
• Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

  2014cited by this paper
• Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats.

  2014cited by this paper
• Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety

  2014cited by this paper
• Changes in bariatric surgery procedure use in Michigan, 2006-2013.

  2014cited by this paper
• Control of hypertension after roux-en-y gastric bypass among obese diabetic patients.

  2014cited by this paper
• Sympathetic inhibition after bariatric surgery.

  2014cited by this paper
• Refractory Hypertension: Determination of Prevalence, Risk Factors, and Comorbidities in a Large, Population-Based Cohort

  2014cited by this paper

• Associations of Visceral Adiposity Index and Body Roundness Index with chronic kidney disease in a Hakka population: mediating effect of blood pressure.

  2026cites this paper
• Trends in the prevalence of apparent treatment-resistant hypertension among U.S. adults, 1999–2018

  2025cites this paper
• Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling

  2023cites this paper
• Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis

  2022cites this paper
• Food protein-derived bioactive peptides for the management of nutrition related chronic diseases.

  2022cites this paper
• Cellular Senescence in Metabolic-Associated Kidney Disease: An Update

  2022influential citation
• Obesity and Hypertension

  2019cites this paper
• Impact of rapid weight loss after bariatric surgery on the prevalence of arterial hypertension in severely obese patients with chronic kidney disease

  2019cites this paper
• Predictors of Resistance Hypertension and Achievement of Target Blood Pressure Levels in Patients with Resistant Hypertension

  2019cites this paper
• Relationship between salivary cortisol and metabolic syndrome in Uygur patients with obese hypertension

  2019cites this paper
• Clinical benefits of renal denervation besides blood pressure reduction

  2018cites this paper
• Investigating the effect of isometric handgrip training frequency on cardiovascular health in medicated hypertensives

  2018cites this paper
• Resistant Hypertension: Mechanisms and Treatment

  2017cites this paper
• Journal of Community Hospital Internal Medicine Perspectives Journal

  year unknowncites this paper